PRICE T ROWE ASSOCIATES INC /MD/

Position in CABA — Cabaletta Bio, Inc.

CIK 80255 BALTIMORE, MD

Position in CABA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,742,076

+$12,552,351 QoQ

Shares Held

4,418,674

+899.1% QoQ

Ownership

2.61%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 139 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. CABA ranks #109 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,742,076	4,418,674	+899.1%	Shares	Sole	2026-08-14
2026-03-31	$1,189,725	442,277	-59.6%	Shares	Defined	2026-05-15
2025-12-31	$2,395,770	1,093,959	-15.5%	Shares	Sole	2026-02-17
2025-09-30	$3,030,180	1,294,949	-40.8%	Shares	Sole	2025-11-14
2025-06-30	$3,324,299	2,187,039	+347.0%	Shares	Sole	2025-08-14
2025-03-31	$677,709	489,321	-6.6%	Shares	Sole	2025-05-14
2024-12-31	$1,189,677	524,087	-5.2%	Shares	Sole	2025-02-14
2024-09-30	$2,609,177	552,792	-5.1%	Shares	Sole	2024-11-14
2024-06-30	$4,355,416	582,275	-4.9%	Shares	Defined	2024-08-14
2024-03-31	$10,447,509	612,398	+16.0%	Shares	Sole	2024-05-15
2023-12-31	$11,980,265	527,765	+3346.1%	Shares	Sole	2024-02-16
2023-09-30	$233,094	15,315	+21.6%	Shares	Defined	2023-11-14
2023-06-30	$162,549	12,591	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.